Carroll Financial Associates’s Evolent Health EVH Stock Holding History

Carroll Financial Associates’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-448	Closed	-$2K	–	1565
2020 Q1	$2K	Hold	448	–	–	﹤0.01%	1287
2019 Q4	$4K	Sell	448 -3	-0.7%	-$24	﹤0.01%	1277
2019 Q3	$3K	Hold	451	–	–	﹤0.01%	1272
2019 Q2	$3K	Hold	451	–	–	﹤0.01%	1303
2019 Q1	$5K	Hold	451	–	–	﹤0.01%	1099
2018 Q4	$9K	Buy	451 +148	+49%	+$3.42K	﹤0.01%	882
2018 Q3	$8K	Hold	303	–	–	﹤0.01%	949
2018 Q2	$6K	Buy	303 +136	+81%	+$2.57K	﹤0.01%	994
2018 Q1	$2K	Hold	167	–	–	﹤0.01%	1140
2017 Q4	$2K	Hold	167	–	–	﹤0.01%	1125
2017 Q3	$3K	Hold	167	–	–	﹤0.01%	1060
2017 Q2	$4K	Buy	+167	New	+$4.02K	﹤0.01%	1019

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

CTA

Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return

Carroll Financial Associates's EVH Position: Q2 2020 in Review

Carroll Financial Associates sold out of Evolent Health (EVH) in Q2 2020, closing a stake of 448 shares — an estimated $2K sold.

Carroll Financial Associates first reported a position in EVH in Q2 2017 and held it in 12 quarters. The position peaked at $9K in Q4 2018. 136 funds tracked by Wall St. Rank hold EVH as of Q2 2020.

Carroll Financial Associates reported no remaining Evolent Health position as of Q2 2020 after selling out during the quarter.
Carroll Financial Associates sold 448 Evolent Health shares in Q2 2020, an estimated $2K.
Carroll Financial Associates first reported a position in Evolent Health in Q2 2017 and held it in 12 quarters.
Carroll Financial Associates's Evolent Health position peaked at $9K in Q4 2018.
136 funds tracked by Wall St. Rank held Evolent Health as of Q2 2020.

Based on Carroll Financial Associates's 13F filing for Q2 2020, filed 9 Jul 2020.